Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

CUSIP: 87978U108

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
4,404,649
Total 13F shares
2,100,798
Share change
-248,877
Total reported value
$7,118,000
Price per share
$3.38
Number of holders
13
Value change
-$1,240,495
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 87978U108?
CUSIP 87978U108 identifies TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q1 2022

As of 31 Mar 2022, Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,100,798 shares. The largest 10 holders included Rock Springs Capital Management LP, FMR LLC, VANGUARD GROUP INC, FIL Ltd, BlackRock Inc., Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, and TWO SIGMA ADVISERS, LP. This page lists 13 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.